WHO Suspends Study of Hydroxychloroquine as COVID-19 Treatment to Review Safety Concerns
(GENEVA) — The World Health Organization said Monday that it will temporarily drop hydroxychloroquine — the anti-malarial drug U.S. President Trump says he is taking — from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to date. In a press briefing, WHO director-general Tedros Adhanom Ghebreyesus said that in light of a paper published last week in the Lancet that showed people taking hydroxychloroquine were at higher risk of death and heart problems, there would be “a temporary pause” on the hydroxychloroquine arm of its g...
Source: TIME: Health - May 25, 2020 Category: Consumer Health News Authors: Maria Cheng and Jamey Keaten / AP Tags: Uncategorized COVID-19 News Desk overnight wire Source Type: news

Can My Family Visit This Weekend? Dr. Mallika Marshall Answers Your Coronavirus Questions
BOSTON (CBS) —  As Massachusetts continues to fight the coronavirus pandemic, the public has plenty of questions. Dr. Mallika Marshall answered some of those sent to her email (drmallika@cbs.com) and Facebook and Twitter accounts. “Is it true that if someone tested positive for COVID-19 that they will always test positive because they have the antibody in them?” –Lina There are two main tests right now. One is a swab in the nose that looks for the actual virus in the body. The other is a blood test that looks for antibodies to the virus. Once the virus is gone from the body,...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 22, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Covid-19 Boston, MA Health Healthcare Status Seen On WBZ-TV Syndicated Local Coronavirus Dr. Mallika Marshall Source Type: news

Large Study Finds No Benefit — and Potential Harm — in Using Hydroxychloroquine for COVID-19
In the largest observational study thus far investigating the drug hydroxychloroquine as a treatment for COVID-19, researchers found little evidence that it helps, and worrying evidence that the medication may cause harm. In a study published May 22 in the journal Lancet, scientists in the U.S. and Switzerland report on an analysis of more than 96,000 people hospitalized with confirmed COVID-19 in 671 hospitals on six continents. Nearly 15,000 patients were treated with one of the following: chloroquine (which is an older version of hydroxychloroquine), hydroxychloroquine, or either of those drugs in combination with an an...
Source: TIME: Health - May 22, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 UnitedWeRise20Disaster Source Type: news

Large Study Finds No Benefit — and Potential Harm — in Using Hydroxychloroquine for COVID-19
In the largest observational study thus far investigating the drug hydroxychloroquine as a treatment for COVID-19, researchers found little evidence that it helps, and worrying evidence that the medication may cause harm. In a study published May 22 in the journal Lancet, scientists in the U.S. and Switzerland report on an analysis of more than 96,000 people hospitalized with confirmed COVID-19 in 671 hospitals on six continents. Nearly 15,000 patients were treated with one of the following: chloroquine (which is an older version of hydroxychloroquine), hydroxychloroquine, or either of those drugs in combination with an an...
Source: TIME: Science - May 22, 2020 Category: Science Authors: Alice Park Tags: Uncategorized COVID-19 UnitedWeRise20Disaster Source Type: news

Ultraviolet Light Treats Influenza?
The healing power of ultraviolet light (UV) has flown under the radar for decades. Yet, it’s one of the most powerful detoxifying agents known to man. It kills bacteria and viruses and can be used in a clinical setting. The therapeutic benefits of light have been known for millennia. Hippocrates, the father of modern medicine, believed light was essential to balance the body and emotions. And there is good reason why, during the Spanish flu pandemic of 1918, medics discovered that severely ill patients had hugely better recovery rates when they were nursed outside and had regular exposure to sunlight.1 You see, UV r...
Source: Al Sears, MD Natural Remedies - May 21, 2020 Category: Complementary Medicine Authors: Dr.A.Sears Tags: Health Source Type: news

How Do You Get Lupus?
Title: How Do You Get Lupus?Category: Diseases and ConditionsCreated: 5/21/2020 12:00:00 AMLast Editorial Review: 5/21/2020 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - May 21, 2020 Category: Anesthesiology Source Type: news

President Trump Defends His Hydroxychloroquine Use Amid Concerns, Says ‘So Far I Seem to Be O.K.’
(WASHINGTON) — President Donald Trump emphatically defended himself Tuesday against criticism from medical experts that his announced use of a malaria drug against the coronavirus could spark wide misuse by Americans of the unproven treatment with potentially fatal side effects. Trump’s revelation a day earlier that he was taking hydroxychloroquine caught many in his administration by surprise and set off an urgent effort by officials to justify his action. But their attempt to address the concerns of health professionals was undercut by the president himself. He asserted without evidence that a study raising a...
Source: TIME: Health - May 20, 2020 Category: Consumer Health News Authors: ZEKE MILLER, MARILYNN MARCHIONE and JONATHAN LEMIRE / AP Tags: Uncategorized COVID-19 Donald Trump News Desk wire Source Type: news

What to Know About Hydroxychloroquine
Here are the facts on hydroxychloroquine, which the president has promoted to fight Covid-19 despite warnings from the F.D.A. that it can cause heart problems. (Source: NYT Health)
Source: NYT Health - May 19, 2020 Category: Consumer Health News Authors: Denise Grady, Katie Thomas, Patrick J. Lyons and Neil Vigdor Tags: Hydroxychloroquine (Drug) Coronavirus (2019-nCoV) Azithromycin (Drug) Drugs (Pharmaceuticals) Preventive Medicine Research Hospitals Clinical Trials Rumors and Misinformation Rheumatoid Arthritis Lupus Erythematosus Food and Drug Adm Source Type: news

COVID-19 Clinical Trials Report Card: Chloroquine and Hydroxychloroquine, CEBM
Chloroquine and hydroxychloroquine (CQ/HCQ) are antimalarial medications and are also used in the treatment of lupus erythematosus and rheumatoid arthritis. Both have been prominently touted as prospective candidates for the treatment and/or prevention of infection by SARS-Cov-2. This has led to an explosion of research into these treatments. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 12, 2020 Category: Consumer Health News Source Type: news

Sex, genes and vulnerability
(Harvard Medical School) Study offers molecular explanation for long-standing observation that certain diseases occur more often or more severely in different sexes. Complement component 4 (C4) genes protect against the autoimmune disorders lupus and Sj ö gren's syndrome while raising risk of severe schizophrenia. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 11, 2020 Category: International Medicine & Public Health Source Type: news

Systemic Lupus Erythematosus --Developing Medical Products for Treatment
Clinical/Medical (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 5, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Race-specific lupus nephritis biomarkers
(University of Houston) A University of Houston biomedical researcher has discovered a difference in urinary biomarker proteins of lupus nephritis in patients according to race. The findings have implications for early diagnosis and new treatments. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 5, 2020 Category: Biology Source Type: news

More Evidence That Trump-Touted Drugs Won't Curb COVID-19
THURSDAY, April 30, 2020 -- Another study casts doubt on the malaria drugs touted by President Donald Trump as potential game-changers against COVID-19. The drugs, chloroquine and hydroxychloroquine, are also used for lupus and rheumatoid... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 30, 2020 Category: General Medicine Source Type: news

New clinical review casts doubt on use of chloroquine and hydroxychloroquine for COVID-19
(Federation of American Societies for Experimental Biology) In its May issue, The FASEB Journal is publishing a comprehensive review on the science and clinical experiences with the drugs chloroquine and hydroxychloroquine, first introduced as effective weapons against malaria, rheumatoid arthritis, and the autoimmune disease lupus. Recent anecdotal reports suggested these drugs might be effective against the SARS-CoV-2 virus, the cause of the COVID-19 pandemic. This new review describes the growing skepticism regarding adoption of chloroquine and hydroxychloroquine for the respiratory infection caused by this virus. (Sour...
Source: EurekAlert! - Infectious and Emerging Diseases - April 30, 2020 Category: Infectious Diseases Source Type: news

IPCA asks USFDA to clarify on Hydroxychloroquine risk
Hydroxychloroquine, besides being administered as an anti-malarial drug, is also used as a chronic therapy by patients suffering from auto immune diseases such as RA and Lupus. In the recent months the drug has been used in several countries including India and US in the treatment of critically ill Covid-19 patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 30, 2020 Category: Pharmaceuticals Source Type: news

Prescriptions Surged as Trump Praised Drugs in Coronavirus Fight
Prescriptions for two antimalarial drugs jumped by 46 times the average when the president promoted them on TV. There ’s no proof they work against Covid-19. (Source: NYT Health)
Source: NYT Health - April 25, 2020 Category: Consumer Health News Authors: Ellen Gabler and Michael H. Keller Tags: Drugs (Pharmaceuticals) Hydroxychloroquine (Drug) Azithromycin (Drug) Coronavirus (2019-nCoV) United States Politics and Government Autoimmune Diseases Lupus Erythematosus Rheumatoid Arthritis Trump, Donald J Food and Drug Administration Source Type: news

After Trump Hypes Use of a Lupus Med Against COVID-19, Lupus Patients Face Shortages
SATURDAY, April 25, 2020 -- Hydroxychloroquine is a key therapy for the autoimmune disease lupus, but interest in it as a potential COVID-19 treatment could make it hard for lupus patients to obtain, experts warn. Hydroxychloroquine is the only... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 25, 2020 Category: General Medicine Source Type: news

FDA Issues Warning About Hydroxychloroquine for COVID-19
On April 24, the U.S. Food and Drug Administration (FDA) issued a MedWatch Safety Alert about the use of hydroxychloroquine or chloroquine for treating COVID-19. After preliminary studies hinted that hydroxychloroquine may help some patients with severe COVID-19 symptoms to improve, the FDA issued an emergency use authorization (EUA) to allow doctors to use the drug on hospitalized patients whose symptoms are not improving. Several studies were also launched to study its effects as a COVID-19 treatment. However, hydroxychloroquine can have negative effects on the heart, contributing to abnormal heart rhythms that can be li...
Source: TIME: Health - April 24, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Janssen Announces Submission of Two Applications to U.S. FDA Seeking Approval of SIMPONI ARIA ® (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
HORSHAM, PA, April 24, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of two supplemental Biologics License Applications (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of SIMPONI ARIA® (golimumab) for the treatment of polyarticular juvenile idiopathic arthritis (pJIA) and juvenile psoriatic arthritis (jPsA), in patients two years of age and older in combination with methotrexate. If approved for these indications, SIMPONI ARIA would be the first anti-tumor necrosis factor (TNF)-alpha biologic agent administered by intravenous infusion av...
Source: Johnson and Johnson - April 24, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Hydroxychloroquine and coronavirus: a guide to the scientific studies so far
The drug – now a partisan wedge issue – has fueled hype and hope, but evidence of its effectiveness remains limitedCoronavirus – live US updatesLive global updatesSee all our coronavirus coverageWith endorsements from a controversial French physician, Fox News and Donald Trump,hydroxychloroquine– an old anti-malarial drug that is today more commonly used to treat lupus – has received a disproportionate amount of attention as a potential treatment for Covid-19.It has also become another partisan political wedge issue in the US:conservative politicians and media figures have hyped studies that s...
Source: Guardian Unlimited Science - April 23, 2020 Category: Science Authors: Julia Carrie Wong in San Francisco Tags: Coronavirus outbreak US news World news Infectious diseases Medical research Science Health Source Type: news

Why Keep Everyone Out Of Work? Dr. Mallika Marshall Answers Your Coronavirus Questions
BOSTON (CBS) – As the number of coronavirus cases continues to grow, we are receiving a number of questions from the public. Dr. Mallika Marshall answered some of the questions sent to WBZ-TV’s Facebook, Instagram, and Twitter accounts. I see so many wearing masks but continually touching the mask and their face. Is this causing more harm than good? – Joseph One of the benefits of wearing a mask, if you wear it properly, is that you’re less likely to touch your hands to your nose or mouth. People touch their face up to 23 times an hour and having a face mask is a reminder not to do that. But masks a...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 16, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated Local Coronavirus Dr. Mallika Marshall Source Type: news

Africa: Understanding Lupus, the Disease Treated By Chloroquine and Hydroxychloroquine
[The Conversation Africa] Chloroquine and hydroxychloroquine - until recently two fairly obscure drugs in the minds of the general public - have hit the headlines of late. This followed controversial statements by US president Donald Trump that they could be used to treat COVID-19. The US Food and Drug Administration has subsequently approved the drugs for "compassionate use" in the treatment of the new coronavirus infection. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 16, 2020 Category: African Health Source Type: news

Vaccines, Antibodies and Drug Libraries. The Possible COVID-19 Treatments Researchers Are Excited About
In early April, about four months after a new, highly infectious coronavirus was first identified in China, an international group of scientists reported encouraging results from a study of an experimental drug for treating the viral disease known as COVID-19. It was a small study, reported in the New England Journal of Medicine, but showed that remdesivir, an unapproved drug that was originally developed to fight Ebola, helped 68% of patients with severe breathing problems due to COVID-19 to improve; 60% of those who relied on a ventilator to breathe and took the drug were able to wean themselves off the machines after 18...
Source: TIME: Health - April 14, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

The Development of a Disease-Specific eCOA/ePRO: The Electronic Lupus...
In this free webinar, the speakers will discuss why lupus research is so complex and how a comprehensive solution such as the eLAS platform can overcome the challenges of complex clinical trials. They...(PRWeb April 14, 2020)Read the full story at https://www.prweb.com/releases/the_development_of_a_disease_specific_ecoa_epro_the_electronic_lupus_assessment_suite_upcoming_webinar_hosted_by_xtalks/prweb17047029.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 14, 2020 Category: Pharmaceuticals Source Type: news

Don't worry, HCQ info's a click away
The move will likely ease the worries of thousands of Indians who have been prescribed the drug for certain ailments — including malaria and autoimmune disorders like rheumatoid arthritis and lupus — but are facing difficulty in getting it after India lifted a ban on its export last week. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 13, 2020 Category: Pharmaceuticals Source Type: news

Fears of Unregulated ‘Wild West’ as COVID-19 Blood Tests Hit the U.S. Market
WASHINGTON — Blood tests for the coronavirus could play a key role in deciding whether millions of Americans can safely return to work and school. But public health officials warn that the current “Wild West” of unregulated tests is creating confusion that could ultimately slow the path to recovery. More than 70 companies have signed up to sell so-called antibody tests in recent weeks, according to U.S. regulators. Governments around the world hope that the rapid tests, which typically use a finger-prick of blood on a test strip, could soon ease public restrictions by identifying people who have previousl...
Source: TIME: Health - April 12, 2020 Category: Consumer Health News Authors: Time Tags: Uncategorized COVID-19 News Desk wire Source Type: news

President Trump is wrong in so many ways about hydroxychloroquine studies. Here are the facts
There are several treatments being studied to prevent or treat coronavirus, but President Trump has been a cheerleader for one in particular: hydroxychloroquine, a drug currently used to treat malaria, lupus and rheumatoid arthritis. (Source: CNN.com - Health)
Source: CNN.com - Health - April 11, 2020 Category: Consumer Health News Source Type: news

Drug shows promise in reversing kidney damage caused by lupus
A drug used for cancer therapy might help prevent oxygen depletion and damage of kidney tissue in lupus patients, a Yale-led study has found. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 8, 2020 Category: Universities & Medical Training Source Type: news

Lupus and arthritis patients facing hydroxychloroquine shortage
When Elaine MacKenzie hears President Trump talk about how a particular drug might be a "game-changer" for people with coronavirus, it's more than just news to her -- it's personal. (Source: CNN.com - Health)
Source: CNN.com - Health - April 8, 2020 Category: Consumer Health News Source Type: news

After Trump's statements about hydroxychloroquine, lupus and arthritis patients face drug shortage
When Elaine MacKenzie hears President Trump talk about how a particular drug might be a "game-changer" for people with coronavirus, it's more than just news to her -- it's personal. (Source: CNN.com - Health)
Source: CNN.com - Health - April 7, 2020 Category: Consumer Health News Source Type: news

India releases hydroxychloroquine stocks amid pressure from Trump
US president called Modi and threatened ‘retaliation’ if country kept full export banCoronavirus – latest updatesSee all our coronavirus coverageIndia has approved some exports ofhydroxychloroquine, an anti-malaria drug being touted as a possible coronavirus treatment, after apparent pressure from Donald Trump, who has been urging Americans to take it.The tablets are used to prevent and treat malaria, lupus and rheumatoid arthritis but over the past week the US president has been aggressively promoting the drug as a treatment for coronavirus, despite there being no conclusive medical evidence to prove its...
Source: Guardian Unlimited Science - April 7, 2020 Category: Science Authors: Hannah Ellis-Petersen South Asia correspondent Tags: India South and Central Asia World news US news Malaria Coronavirus outbreak Infectious diseases Medical research Science Source Type: news

As many as 4,000 patients seriously ill with coronavirus are being treated with hydroxychloroquine
Health officials have sent hydroxychloroquine, typically used to treat malaria and lupus, to 56 hospitals across New York to treat patients suffering serious complications from the virus. (Source: the Mail online | Health)
Source: the Mail online | Health - April 7, 2020 Category: Consumer Health News Source Type: news

Dawn of New Lupus Nephritis Treatment After AURORA Trial Dawn of New Lupus Nephritis Treatment After AURORA Trial
The addition of a novel calcineurin inhibitor to the standard of care improves renal response in patients with lupus nephritis, results from the phase 3 AURORA trial show.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 27, 2020 Category: Consumer Health News Tags: Nephrology News Source Type: news

Vital drug for people with lupus running out after unproven Covid-19 link
Italy and France now prescribing hydroxychloroquine for coronavirus despite fact its effectiveness is unknownCoronavirus – latest updatesSee all our coronavirus coverageA stampede for an unproven “cure” for Covid-19 is clearing the pharmacy shelves of a medicine that is vital for up to 5 million people around the world suffering from lupus, as countries bow to populist pressure and abandon the trials that would show whether hydroxychloroquine works against coronavirus infection.Both Italy and France have said doctors can now prescribe hydroxychloroquine – a less toxic version of the malaria drug chl...
Source: Guardian Unlimited Science - March 27, 2020 Category: Science Authors: Sarah Boseley Health Editor Tags: Coronavirus outbreak Science Infectious diseases World news France Italy US news UK news Medical research Europe Source Type: news

Drug Eyed As Potential Coronavirus Treatment Being Hoarded, Leaving Patients In Need Without
BOSTON (CBS) – A drug that President Donald Trump has touted as a possible treatment for coronavirus is now in short supply. While the FDA has not yet approved hydroxychloroquine for COVID-19, some people are hoarding it, leaving patients who regularly rely on the medication scrambling. “It would be a gift from God if that worked. It would be a big game changer,” Trump said of the anti-malarial drug. Dr. Anthony Fauci, the Director of the National Institute of Allergy and Infectious Disease, and a prominent member of the White House Coronavirus Task Force has cautioned that evidence of its effectiveness i...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 24, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Syndicated Local Coronavirus Source Type: news

Lupus patients across the US face shortages of 'life-saving' drug
Several lupus sufferers including Bonnie Lieberman, from California, are struggling to find Plaquenil, a medication whose generic form has been touted as a treatment for coronavirus. (Source: the Mail online | Health)
Source: the Mail online | Health - March 24, 2020 Category: Consumer Health News Source Type: news

President Trump Called Hydroxychloroquine a ‘Game Changer,’ But Experts Warn Against Self-Medicating With the Drug. Here’s What You Need to Know
After President Trump, late last week, expressed great confidence in the promise of a new COVID-19 therapy that combines two existing prescription medications, supplies of these two drugs rapidly began disappearing from pharmacy shelves. The U.S. Food and Drug Administration allowed an Indian company previously restricted from importing drug products into the US to now start manufacturing one of the drugs. And U.S. plants began gearing up to produce enough to meet the surge in demand. But in those few days, a few people who began self medicating with the drugs in an effort to prevent COVID-19 have died, and others have bee...
Source: TIME: Health - March 24, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Man Dies After Taking Chloroquine for Coronavirus
Chloroquine is approved in the United States to treat malaria, lupus and rheumatoid arthritis, but President Donald Trump has promoted it as a possible treatment for COVID-19, CNN reported. (Source: WebMD Health)
Source: WebMD Health - March 24, 2020 Category: Consumer Health News Source Type: news

But you don't look sick? How broad categories like autoimmune impact patient experience
(Drexel University) Patients with autoimmune diseases often have an illness experience riddled with symptom ambiguities and shifting diagnoses. A new Drexel University study found that one way patients and physicians can work through the difficulty and frustration of communicating about these conditions is to use both broad diagnostic terms, like 'autoimmune disease,' as well as narrow ones, such as 'lupus or MS.' (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 24, 2020 Category: International Medicine & Public Health Source Type: news

Increase in demand for drugs to treat coronavirus leads to shortages
An increase in requests for drugs that could help treat coronavirus has led to a shortage for others who normally rely on the medications. Those with the autoimmune disease Lupus have been hit particularly hard. Carter Evans reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 24, 2020 Category: Consumer Health News Source Type: news

Why Hoarding Of Hydroxychloroquine Needs To Stop
Despite Trump's public remarks, infectious disease experts say it's premature to think hydroxychloroquine will help against COVID-19. And patients with lupus or rheumatoid arthritis rely on the drug.(Image credit: NIAID/Flickr) (Source: NPR Health and Science)
Source: NPR Health and Science - March 23, 2020 Category: Consumer Health News Authors: Martha Bebinger Source Type: news

Potential Coronavirus Treatment Could Lead To Shortage Of Drug For Lupus Patients
SUTTON (CBS) — President Trump has been dropping the names of several medications being tested to treat COVID-19. But one of them — hydroxychloroquine — is commonly used to treat lupus symptoms. With new recognition of the drug, lupus patients are worried they may lose access to a drug they rely on. When Cheryl Hamel, a lupus patient from Sutton, called her pharmacy Sunday morning to get the medication she takes to manage her lupus symptoms, she was surprised by what the pharmacist told her. “They told me it was too soon to get it refilled, and what they had at the moment was being saved for COVID p...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 23, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Syndicated Local Coronavirus Health News Sutton News Source Type: news

Lupus patients struggle to get vital drug after Trump comments
Hydroxychloroquine has not been approved to treat coronavirus, and the nation's top infectious disease expert says there is no evidence it is effective. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 23, 2020 Category: Consumer Health News Source Type: news

Amid Hydroxychloroquine Hopes, Lupus Patients Face Shortages Amid Hydroxychloroquine Hopes, Lupus Patients Face Shortages
Limited evidence that a common lupus drug might combat COVID-19 is driving up demand. Lupus patients are worried.Undark (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 23, 2020 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Trump ’s Embrace of Unproven Drugs to Treat Coronavirus Defies Science
Doctors and patients also worry that the president ’s rosy outlook for the treatments will exacerbate shortages of old malaria drugs relied on by patients with lupus and other debilitating conditions. (Source: NYT Health)
Source: NYT Health - March 21, 2020 Category: Consumer Health News Authors: Katie Thomas and Denise Grady Tags: Drugs (Pharmaceuticals) United States Politics and Government Coronavirus (2019-nCoV) Rheumatoid Arthritis Lupus Erythematosus Bayer AG Mylan Inc National Institute of Allergy and Infectious Diseases Fauci, Anthony S Trump, Donald J yo Source Type: news

Association of child abuse with systemic lupus erythematosus in Black women during adulthood - Cozier YC, Barbhaiya M, Castro-Webb N, Conte C, Tedeschi S, Leatherwood C, Costenbader KH, Rosenberg L.
OBJECTIVE: Exposure to psychosocial stressors may contribute to the onset of systemic lupus erythematosus (SLE) through dysregulation of the adaptive stress response. We assessed the relationship of childhood physical and sexual abuse to SLE risk among Bla... (Source: SafetyLit)
Source: SafetyLit - March 18, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Antimalarials May Cut Risk for Type 2 Diabetes in Lupus Patients
THURSDAY, March 5, 2020 -- Adherence to antimalarials may offer a protective effect against type 2 diabetes mellitus (T2DM) among patients with systemic lupus erythematosus (SLE), according to a study recently published in Arthritis Care&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 5, 2020 Category: Pharmaceuticals Source Type: news

Research Finds Contagious Staph in Lupus-Related Skin Rashes
Title: Research Finds Contagious Staph in Lupus-Related Skin RashesCategory: Health NewsCreated: 2/28/2020 12:00:00 AMLast Editorial Review: 3/2/2020 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - March 2, 2020 Category: Rheumatology Source Type: news

Research Finds Contagious Staph in Lupus-Related Skin Rashes
FRIDAY, Feb. 28, 2020 -- Skin rashes in people with lupus may have high levels of disease-causing bacteria that can spread to other people, according to a new study. Researchers found that half of rashes in patients with lupus had abnormally high... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 28, 2020 Category: General Medicine Source Type: news

Study findings show which alternative hair loss remedies work: Rosemary oil and caffeine revealed to be the most effective therapies
(Natural News) It’s normal for a person to experience hair loss: On average, a person can lose up to 100 hairs from his scalp every day. However, while most people grow them back, those with alopecia experience extreme hair loss, either due to diseases like lupus, thyroid issues or diabetes; environmental exposure; medication; or even poor nutrition.... (Source: NaturalNews.com)
Source: NaturalNews.com - February 27, 2020 Category: Consumer Health News Source Type: news